Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
EliseAI›
Analysis
AddedFeb 15, 2024
UpdatedJun 26, 2026
EliseAI

EliseAI

Series E

EliseAI is a New York-based AI company automating complex healthcare and housing systems.

HQ
New York City, NY, US
Founded
2017
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  4. 04Pricing Strategy
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  4. 04Pricing Strategy

Product Overview

EliseAI offers a conversational AI platform that automates operations for housing and healthcare organizations. Core capabilities include resident and patient communications, leasing automation, maintenance triage, appointment scheduling, and billing inquiries through natural language interfaces.

The platform supports voice and text channels, integrates with existing CRM and EHR systems, and provides analytics dashboards for operational visibility. Product modules include EliseCRM for housing operators and HealthAI for healthcare providers.

Market Outlook

The AI automation market for housing and healthcare is expected to grow rapidly as labor shortages increase demand for conversational AI in property management and patient engagement. EliseAI operates at the intersection of these two sectors, which together represent a multibillion-dollar addressable market.

Competitive dynamics favor vertically integrated platforms with deep enterprise integrations over generalist chatbot providers. Regulatory requirements in healthcare and long sales cycles in housing create barriers to entry that benefit established players with proven deployment track records.

Competitive Advantages

EliseAI leverages proprietary generative AI trained on housing and healthcare domain data, enabling higher accuracy in task-specific conversations than general-purpose models. Its platform integrates with existing property management and electronic health record systems, reducing deployment friction.

The company maintains a unified codebase across housing and healthcare verticals, allowing feature improvements to benefit both sectors. Early market entry and deep enterprise relationships create switching costs for large customers.

Pricing Strategy

EliseAI uses a sales-led enterprise pricing motion rather than publishing self-serve plans. Its contact page routes prospective customers to a sales team to discuss becoming a customer and finding solutions that meet each organization's needs.

The company positions its platform for housing and healthcare operators through demo and request paths alongside dedicated partnership channels. This structure indicates pricing is scoped around customer vertical, implementation requirements, system integrations, and operational workflows rather than a fixed public price list.